Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy

Immunoglobulin A nephropathy (IgAN) is common worldwide and has heterogeneous phenotypes. Predicting long-term outcomes and stratifying risk are important for clinical decision making and designing future clinical trials.Multicenter retrospective cohort study of 2,047 patients with IgAN.Derivation and validation cohorts composed of 1,022 Chinese patients with IgAN from a single center and 1,025 patients with IgAN from 18 renal centers,...